Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tuesdaynightridon Nov 12, 2014 11:01am

207 Views

Post# 23120335

RE:RE:get the rats on top of this

Mickey2, Every board has it's share of twits. Unfortunately this board has more than one but count yourself among them. The purpose of the U of Toledo rat trial was to have independent confirmation of the TLT results hence the word INDEPENDENT. Beyond that, there is no published rat trial data from TLT or anyone else at this point. When you post, please post facts.

Bullboard Posts

Covalon Technologies posts third profitable quarter in a row